Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
autoimmune diseases
Immunotherapy
allergy
food allergy
ARDS
covid-19
celiac diseases
Date founded
2016
Funding rounds raised
Total raised
$83K
from 2 investors over 2 rounds
A
Allero Therapeutics raised undisclosed on April 17, 2019
Investors: Swanbridge Capital
A
Allero Therapeutics raised $83K on September 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)